-+ 0.00%
-+ 0.00%
-+ 0.00%

VOYAGER THERAPEUTICS - TO INITIATE VY1706 CLINICAL TRIAL IN ADULTS WITH EARLY ALZHEIMER'S; DOSING EXPECTED H2 2026

Reuters·06/01/2026 12:00:02

Please log in to view news